Principal Financial Group’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-77,102
Closed -$1.85M 2235
2025
Q1
$1.85M Sell
77,102
-285
-0.4% -$10.1K ﹤0.01% 1781
2024
Q4
$2.89M Buy
77,387
+3,281
+4% +$153K ﹤0.01% 1732
2024
Q3
$3.7M Sell
74,106
-4,942
-6% -$192K ﹤0.01% 1648
2024
Q2
$2.74M Buy
79,048
+55,415
+234% +$2.19M ﹤0.01% 1710
2024
Q1
$1.29M Sell
23,633
-4,302
-15% -$213K ﹤0.01% 1839
2023
Q4
$1.2M Buy
27,935
+9,005
+48% +$280K ﹤0.01% 1819
2023
Q3
$492K Buy
18,930
+2,803
+17% +$58.3K ﹤0.01% 1954
2023
Q2
$386K Buy
16,127
+2,827
+21% +$48.7K ﹤0.01% 2009
2023
Q1
$182K Buy
13,300
+404
+3% +$6.43K ﹤0.01% 2199
2022
Q4
$179K Buy
+12,896
New +$182K ﹤0.01% 2220

Other funds holding BHVN

Principal Financial Group's BHVN Position: Q2 2025 in Review

Principal Financial Group sold out of Biohaven (BHVN) in Q2 2025, closing a stake of 77,102 shares — an estimated $1.85M sold.

Principal Financial Group first reported a position in BHVN in Q4 2022 and held it in 10 quarters. The position peaked at $3.7M in Q3 2024. 249 funds tracked by Wall St. Rank hold BHVN as of Q2 2025.

  • Principal Financial Group reported no remaining Biohaven position as of Q2 2025 after selling out during the quarter.
  • Principal Financial Group sold 77,102 Biohaven shares in Q2 2025, an estimated $1.85M.
  • Principal Financial Group first reported a position in Biohaven in Q4 2022 and held it in 10 quarters.
  • Principal Financial Group's Biohaven position peaked at $3.7M in Q3 2024.
  • 249 funds tracked by Wall St. Rank held Biohaven as of Q2 2025.

Based on Principal Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.